Delivery Order SPE2D021D0008-SPE2D324F097E

Award Date 7/8/24
Potential Completion Date 7/11/24
Potential Value $1.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Yaphank, NY 11967, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency Troop Support Medical awarded a $1,852.50 firm fixed price delivery order to American Regent Inc., a pharmaceutical manufacturer, to supply atropine sulfate injection. This order was placed under an existing indefinite delivery contract with the DLA Troop Support Medical, which allows American Regent to provide a range of pharmaceuticals and medical supplies to support military healthcare programs. No set-aside designation was used for this specific order....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a pharmaceutical manufacturer and distributor, for the supply of atropine sulfate injection. The contract, valued at $1,852.50, is a firm-fixed-price delivery order with a period of performance ending on July 11, 2024. American Regent Inc. holds multiple federal contract vehicles, including a $131.4 million Federal Supply Schedule contract with the Department of Veterans...
This federal contract award to American Regent Inc. is for the delivery of atropine sulfate injection, a critical care medication, to support military medical treatment facilities worldwide. The award, valued at $1,852.50, was made by the Defense Logistics Agency (DLA) Troop Support Medical and is a firm-fixed-price delivery order contract. American Regent Inc. is a pharmaceutical manufacturer and distributor that specializes in injectable drugs and sterile pharmaceutical preparations. The...
This federal contract award, with ID SPE2D021D0008|SPE2D324F097D, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor American Regent Inc. The $1,852.50 firm-fixed-price delivery order is for the supply of atropine sulfate injection, a critical care medication, to support military healthcare programs and medical readiness for the U.S. armed forces. American Regent Inc. is a pharmaceutical manufacturer and distributor that holds multiple federal contract...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a subsidiary of Daiichi Sankyo Group. The $2,778.75 order is for the delivery of atropine sulfate injection, a critical care pharmaceutical product, to support the DLA's mission of maintaining medical readiness for the U.S. armed forces. American Regent Inc. has been awarded numerous prime federal contracts, primarily delivery orders, to provide essential medical...
This federal contract award, valued at $28,713.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a pharmaceutical manufacturer and distributor. The contract is for the delivery of atropine sulfate injection, a critical care medication, to support military healthcare programs and maintain medical readiness for the armed forces. The award is a firm fixed-price delivery order against an existing indefinite delivery, indefinite quantity (IDIQ)...
This is a $1,852.50 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a pharmaceutical manufacturer and distributor, for the supply of atropine sulfate injection. The delivery order falls under a larger $13.8 million single award indefinite delivery/indefinite quantity (IDIQ) contract between American Regent and the DLA, which provides various pharmaceuticals including atropine, glycopyrrolate, and hydroxyzine to...
American Regent Inc. has been awarded a $185 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to supply atropine sulfate injection. The delivery order has a period of performance through August 21, 2023 for the pharmaceutical product to be delivered to a location in East Yaphank, New York. No set-aside provisions were applied to this award to supply the critical care medication from the prime vendor,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a pharmaceutical manufacturer and distributor. The $596,802.58 firm-fixed-price delivery order contract is for the supply of various medical products, including atropine sulfate injection, glycopyrrolate injection solution, and hydroxyzine tablets. The contract has an ultimate completion date of October 28, 2025 and was awarded on September 24, 2024. American Regent Inc....
The Defense Logistics Agency Troop Support Medical awarded a $1,667 firm fixed price delivery order to American Regent Inc. for 4561609644 Atropine Sulfate Injection. American Regent Inc. will deliver the requested pharmaceutical product from its East Yaphank, New York division under the terms of the contract, which runs from July 26, 2023 through July 31, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports the Department of Defense by...
  • SPE2D021D0008
    Indefinite Delivery Contract
  • SPE2D021D0008-SPE2D324F097E
    Delivery Order

The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $1,852.50 firm-fixed-price delivery order to American Regent Inc., a pharmaceutical manufacturer and distributor, for the supply of atropine sulfate injection. This order was issued against an existing $13.8 million single-award indefinite delivery/indefinite quantity (IDIQ) contract between the DLA and American Regent, awarded in September 2021 for the provision of various pharmaceuticals to support military medical treatment facilities worldwide through September 2031. The contract has no set-aside designation. American Regent specializes in producing injectable drugs and other sterile pharmaceutical preparations and has been awarded numerous federal contracts to supply critical care medications to the U.S. government, primarily through the DLA.

Generated 10/7/24, 10:47 AM